Professor Hisham Mehanna is the Chair of Head and Neck Surgery, and Director of the Institute of Head and Neck Studies and Education, at the School of Cancer Sciences, University of Birmingham.
Hisham’s clinical interests are recurrence head and neck cancer surgery and thyroid and minimal access parathyroid surgery. Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £10million in research grants. The main areas of his research are Human Papillomavirus-associated head and neck cancer and thyroid cancer. His research themes are drug development and redeployment, biomarkers of treatment response and early and late phase clinical trials in head and neck cancer. He is chief investigator of several multicentre and multinational clinical trials, including the PET NECK trial, published in the NEJM in 2016.
He is currently the Chair of the UK’s National Cancer Research Institute’s head and neck group, responsible for all head neck cancer research in the UK. He is also President of the British Association of Head Neck Oncologists (BAHNO) and past Chair of the Research Committee of BAHNO, the UK’s multi-disciplinary professional body, and the Continuing Professional Development Group of the British Association of Otorhinolaryngologists head and neck surgeons (ENT-UK).